Research on high-grade tumors is ongoing, with efforts focused on understanding the genetic and molecular mechanisms that drive their aggressive behavior. Advances in precision medicine and the development of new targeted therapies and immunotherapies are promising areas of research. Clinical trials are continually exploring new treatment options and combinations to improve outcomes for patients with high-grade tumors.
